Why Infinity Pharmaceuticals Is Skyrocketing Today

What happened?Shares of biotech company Infinity Pharmaceuticals (NASDAQ: INFI) are soaring through the roof on Thursday following the company’s release of data from a phase 2 clinical trial for one of its pipeline candidates. As of 12:03 p.m. EST, the drugmaker’s stock was up byRead MoreMarketsMarkets Feed